James Loerop
Corporate Officer/Principal en ACLARIS THERAPEUTICS, INC. .
Fortuna: 183 524 $ al 30/04/2024
Origen de la red de primer grado James Loerop.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 23 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a James Loerop a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Medical/Nursing Services | President Director/Board Member Founder Corporate Officer/Principal | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
MERUS N.V. | Biotechnology | Director/Board Member Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Widener University | College/University | Masters Business Admin Graduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
ACERAGEN, INC. | Biotechnology | Director/Board Member Chairman | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Rowan University | College/University | Undergraduate Degree | |
PROVENTION BIO, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Ottawa | College/University | Doctorate Degree | |
Trigenesis Therapeutics, Inc.
Trigenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigenesis Therapeutics, Inc. operates as dermatology company, The company was founded by Neal S. Walker and Stephen A. Tullman on September 23, 2003 and is headquartered in Montgomery, PA. | Pharmaceuticals: Major | Founder | |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Director/Board Member | |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
Myota, Inc.
Myota, Inc. Packaged SoftwareTechnology Services Myota, Inc. engages in the provision of data security management solutions. The company was founded by Jae Yoon Chung and is headquartered in Chesterbrook, PA. | Packaged Software | Director/Board Member | |
Zoomi, Inc.
Zoomi, Inc. Information Technology ServicesTechnology Services Zoomi, Inc. provides elearning data to companies. Its products include zoomi engine, zoomi dashboard, and zoomi player. Its artificial intelligence studies learner behaviors and patterns to understand what each employee knows, what still needs to be taught and how to best deliver that information automatically. The company was founded by Mung Chiang, Ju William, and James Walker in January 2015 and is headquartered in Malvern, PA. | Information Technology Services | Director/Board Member | |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Corporate Officer/Principal | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Active Protective Technologies, Inc.
Active Protective Technologies, Inc. Miscellaneous ManufacturingProducer Manufacturing Active Protective Technologies, Inc. develops medical technology solutions. It provides a smartbelt that can determine a human fall, and deploys airbags to protect the hips of older adults. The device also has all functionality of medical alert pendants, and will therefore wirelessly alert caregivers. The company was founded by Drew Lakatos and Robert F. Buckman and is headquartered in Philadelphia, PA. | Miscellaneous Manufacturing | Director/Board Member | |
MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Philadelphia College of Osteopathic Medicine | College/University | Doctorate Degree | |
ALDEYRA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 38 |
Reino Unido | 3 |
Países Bajos | 2 |
Canadá | 2 |
Sectorial
Health Technology | 24 |
Consumer Services | 8 |
Commercial Services | 6 |
Technology Services | 3 |
Finance | 3 |
Operativa
Director/Board Member | 108 |
Corporate Officer/Principal | 45 |
Independent Dir/Board Member | 32 |
Chairman | 21 |
Undergraduate Degree | 20 |
Las relaciones más conectadas
Insiders | |
---|---|
Andrew Schiff | 35 |
William Humphries | 25 |
Neal Walker | 24 |
Maxine Gowen | 23 |
Anand Mehra | 18 |
Bryan Reasons | 16 |
Andrew Powell | 16 |
Vin Milano Milano | 14 |
Frank Ruffo | 9 |
Christopher Molineaux | 9 |
Douglas Manion | 8 |
Gail Cawkwell | 7 |
Joseph Monahan | 5 |
Jon Scott Jacobsen | 5 |
Robert A. Doody | 5 |
- Bolsa de valores
- Insiders
- James Loerop
- Conexiones Empresas